- IMGO Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Imago BioSciences (IMGO) 8-K12 Dec 22Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at ASH 2022Financial data
Company Profile